Conference Coverage
Conference Coverage
Aerobic exercise can reduce AFib frequency, severity: ACTIVE-AF
Conference Coverage
EMPEROR-Preserved: Empagliflozin scores HFpEF breakthrough
Empagliflozin is the first treatment to produce an unequivocal, hard-endpoint benefit in patients with heart failure with preserved ejection...
Conference Coverage
Eyes on ESC ‘21: Hope for EMPEROR-Preserved, guidelines remade
But the congress will feature far more than, potentially, results the heart failure world has been longing to see and a raft of new guidelines....
Conference Coverage
Low-dose aspirin linked to lower dementia risk in some
Two cohorts suggest long-term use may be beneficial, but primarily in those with cardiovascular risk.
Conference Coverage
DOACs best aspirin after ventricular ablation: STROKE-VT
Cerebrovascular protection was far better on DOACs after catheter ablation for VT or extrasystoles in the trial and may yet be further improved....
Conference Coverage
Inflammatory diet is linked to dementia
Framingham Heart Study Offspring Cohort analysis reveals ties to all-cause dementia, but not Alzheimer’s dementia.
Conference Coverage
ESC heart failure guideline to integrate bounty of new meds
It has a simple answer to a seemingly complex issue: how to merge the newly approved with mainstay drug therapies. And it conditionally okays meds...
Conference Coverage
The first signs of elusive dysautonomia may appear on the skin
Conference Coverage
Younger adults with HIV have higher CVD risk but low ASCVD scores
Conference Coverage
Long COVID seen in patients with severe and mild disease
A Swiss study shows how even mild COVID cases can lead to debilitating symptoms, according to Dr. Christopher Terndrup.
Conference Coverage
ADA/EASD draft guidance aims to bring adults with type 1 diabetes out of shadows
The new draft ADA/EASD consensus report offers an algorithm for diagnosing type 1 diabetes, a clear call for state-of-the-art technology, and an...